Taurine: 2-aminoethanesulfonic acid
Taurine is an organic compound with the molecular formula C2H7NO3S. Its skeleton consists of two carbon atoms carrying an amino group at one end and a sulfonic acid group at the other. Because the acidic group is a sulfonic acid rather than a carboxylic acid, taurine is not a classical amino acid and is not incorporated into proteins; the literature describes it as an aminosulfonic acid.
Friedrich Tiedemann and Leopold Gmelin isolated the substance from ox bile in 1827, which is the origin of the name, derived from the Latin Bos taurus. Taurine is a colourless crystalline solid, melts at around 328 degrees Celsius with decomposition beginning near 300 degrees Celsius, and dissolves readily in water at roughly 100 grams per litre. In aqueous solution it exists as a zwitterion over a wide pH range, which accounts for both the high melting point and the water solubility. Industrially it is produced by chemical synthesis, usually from ethylene oxide and sodium bisulfite or from aziridine; extraction from animal material plays no commercial role.
Biosynthesis and distribution in the body
The human body forms taurine from the sulfur-containing amino acid cysteine. Cysteine dioxygenase oxidises cysteine to cysteine sulfinic acid, which is decarboxylated by cysteine sulfinic acid decarboxylase and then oxidised to taurine. Activity of the decarboxylase is comparatively low in humans, and it is very low in newborns and absent in cats, for which taurine is a dietary essential. Taurine is one of the most abundant free amino compounds in mammalian tissue, with high concentrations in heart muscle, skeletal muscle, retina, brain, platelets and leukocytes. Cellular uptake runs through the transporter TauT, and the kidney regulates the body pool by adjusting reabsorption.
Documented physiological roles
- Bile acid conjugation. In the liver, taurine is conjugated with bile acids to form taurocholic acid and related compounds. These conjugates remain ionised in the intestine and act as emulsifiers in the digestion of fats and in the absorption of fat-soluble vitamins.
- Osmoregulation. Taurine is one of the principal organic osmolytes of mammalian cells. Cells accumulate or release it in response to changes in extracellular osmolarity, particularly in brain, kidney and muscle.
- Calcium handling. In cardiac and skeletal muscle, taurine modulates calcium fluxes at the sarcoplasmic reticulum, which is why it appears in the literature on excitation-contraction coupling.
- Neuromodulation. Taurine binds to glycine receptors and to GABA-A receptors and is described in the literature as a neuromodulator rather than a classical neurotransmitter.
- Mitochondrial tRNA modification. Taurine-containing modifications of mitochondrial transfer RNA are required for correct translation of certain mitochondrial proteins. Defects in this pathway are the basis of the MELAS group of mitochondrial disorders.
- Taurine chloramine. In neutrophils, taurine reacts with hypochlorous acid to form taurine chloramine, a less reactive compound. This reaction is studied as part of the chemistry of the inflammatory response.
Dietary sources and typical amounts
Taurine occurs in animal foods: meat, fish, shellfish, and in smaller amounts in dairy products. Scallops, mussels and dark poultry meat are among the richest sources. Plant foods contain almost none, so plasma and urinary taurine are on average lower in people following vegan and vegetarian diets; whether this difference has any consequence in adults whose own synthesis is intact is an open question. Human breast milk contains taurine, and infant formula in the EU is routinely supplemented with it.
Energy drinks are a well known commercial source and typically declare about 400 milligrams per 100 millilitres, that is roughly 1,000 milligrams per 250 millilitre can. The European Food Safety Authority assessed taurine in energy drinks in 2009 and in 2015 and considered exposure at these levels in adults to be of no safety concern. In 2012 EFSA derived an observed safe level of 6 grams per day for taurine in supplements for adults.
What studies have examined
- Exercise physiology. Trials in athletes, usually with 1 to 6 grams taken before exercise, have measured time to exhaustion, peak power and markers of muscle damage such as creatine kinase. A 2018 meta-analysis of ten trials with 103 participants reported small mean differences in endurance measures; the individual trials were short, the protocols varied and several combined taurine with caffeine, so attribution to taurine alone is limited.
- Cardiovascular parameters. Randomised trials have measured blood pressure in participants with elevated readings during taurine intake, typically 1.6 grams per day for up to twelve weeks, and reported differences of a few millimetres of mercury in the pooled analyses. Participant numbers were small, and the clinical meaning is not established.
- Glucose metabolism. Cell and rodent studies report effects on insulin signalling. Human trials are few and small and have not produced a consistent picture.
- Retina. Taurine depletion causes retinal degeneration in cats and in rodent models, and case reports describe retinal changes in people on long-term parenteral nutrition without taurine. These are findings in deficiency states, not in people with normal intake.
- Ageing research. A study published in Science in 2023 by Singh and colleagues reported that daily taurine administration was associated with a 10 to 12 percent longer median lifespan in mice, with accompanying measurements in rhesus monkeys over six months and observational human data showing lower circulating taurine at higher ages. The authors themselves described the human part as associative and called for randomised trials. A subsequent longitudinal analysis published in 2025, using repeated measurements in humans and in monkeys, found no consistent decline of circulating taurine with age, which puts the premise of the age-related decline into question. The matter is unresolved.
All quantities above describe study protocols and are not intake recommendations.
Safety, interactions and groups requiring caution
Taurine has been examined in a large number of short trials without serious adverse effects being reported at the doses used. Points noted in the literature and in product information:
- Very high intake has been associated with nausea, headache and diarrhoea.
- Interactions with medicines are possible; people on regular medication, in particular antihypertensives and lithium, should consult a physician before intake.
- Pregnant and breastfeeding women are advised against supplementation because of insufficient data.
- In people with impaired kidney function, elimination may be altered.
- In energy drinks, the relevant exposure question concerns the caffeine and sugar content rather than taurine.
Open questions
- Long-term data on supplementation in humans are lacking.
- Whether the findings from rodent lifespan studies have any counterpart in humans is untested.
- Appropriate markers for taurine status in humans are not established, which makes trials hard to compare.
- Possible interactions with other nutrients studied in ageing research are largely unexamined.
Summary
Taurine is a well characterised aminosulfonic acid with documented roles in bile acid conjugation, osmoregulation, calcium handling and mitochondrial translation. Its visibility in ageing research comes from a single prominent mouse study whose central premise has since been questioned. Human evidence is limited to small, short trials, and safety data cover the short term.